SCHEMBL14723648

SCHEMBL14723648

C=C(c1nc(Cl)cc2ccccc12)C(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.34
KDM4E B2RXH2 2/20 0.34
TRPM4 Q8TD43 1/20 0.32
MAPT P10636 3/20 0.31
CYP1A2 P05177 3/20 0.31
HTT P42858 2/20 0.31
NQO2 P16083 1/20 0.31
CYP2A6 P11509 1/20 0.31
IGF1R P08069 1/20 0.31
ALDH1A1 P00352 3/20 0.31
HSD17B10 Q99714 2/20 0.31
USP2 O75604 1/20 0.31
HIF1A Q16665 1/20 0.31
CYP1B1 Q16678 1/20 0.31
KMT2A Q03164 3/20 0.30
CYP2C19 P33261 3/20 0.30
MEN1 O00255 2/20 0.30
LMNA P02545 1/20 0.30
CYP3A4 P08684 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31729469 0.85 L3MBTL1 (0.35) L3MBTL1KDM4ETRPM4MAPTCYP1A2
SCHEMBL13379434 0.81 KDM4E (0.40) L3MBTL1KDM4EMAPTCYP1A2HTT
SCHEMBL12849639 0.75 MAPT (0.46) L3MBTL1KDM4EMAPTCYP1A2HTT
SCHEMBL16505189 0.74 KDM4E (0.40) L3MBTL1KDM4EMAPTCYP1A2ALDH1A1
SCHEMBL14723767 0.73 CYP2C19 (0.38) L3MBTL1KDM4EMAPTCYP1A2HTT
SCHEMBL755479 0.73 MEN1 (0.50) KDM4EMAPTCYP1A2HTTIGF1R
SCHEMBL14664101 0.71 EGLN1 (0.45) KDM4EMAPTCYP1A2HTTALDH1A1
SCHEMBL12798535 0.71 KDM4E (0.40) KDM4EMAPTCYP1A2HTTALDH1A1
SCHEMBL13387698 0.71 PAK1 (0.41) L3MBTL1KDM4EMAPTCYP1A2HTT
SCHEMBL31547755 0.71 KDM4E (0.57) L3MBTL1KDM4EMAPTHTTIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383094-B2 inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds, for example, by competitive inhibition; used to treat or prevent viral contamination of materials BRISTOL-MYERS SQUIBB COMPANY (US) 2013-02-26 US disclosed